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Nanotechnology has become the most advanced type of drug delivery system 
within the last decade. This advancement shifted the focus on small carriers to increase 
the efficiency of the drugs. Among these, gold nanoparticles (GNPs) were found to have 
profound biomedical applications. In current research, kanamycin embedded GNPs were 
prepared in a single step, single phase, and bio-friendly (green synthesis) procedure. The 
synthesized Kanamycin-GNPs (Kan-GNPs) were spherical in shape and had a size range 
of 15 ± 3 nm. The chosen kanamycin is an aminoglycosidic antibiotic that is isolated 
from Streptomyces kanamyceticus. These special antibiotic GNPs are further 
characterized using several analytical methods like Transmission Electron Microscopy 
(TEM), Energy Dispersive Spectroscopy (EDS), Fourier Transform Infrared 
Spectroscopy (FTIR), and Ultra-Voilet/Visible spectroscopy (UV/Vis spectroscopy). The 
following research is a direct bio-friendly embedment of an antibiotic agent on the 
surface of the GNPs without any secondary capping agent or surface modification 
procedures. 
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1. INTRODUCTION 
1.1.  Bacteria 
Bacteria are prokaryotes, simpler than any eukaryotic cell, but have more or less 
similar features. The nucleic acid in an eukaryotic cell is similar to the plasmids in 
bacteria. Bacteria have an extraordinary ability to transfer or exchange a gene which 
makes them survive in extreme environments by developing resistance. The most 
important structure of bacteria is the cell 
wall whose composition and integrity 
changes with change in species.(1) The 
cell wall is made of carbohydrates called 
peptidoglycan. Based on thickness of 
the peptidoglycan in the cell wall and 
their response towards crystal violet 
dye, bacteria are divided into two types, 
as gram positive and gram negative 
bacteria.(1) Gram positive bacteria have 
thick cell walls which show purple color 
when stained with crystal violet as 
shown in Fig. (1a) where as gram negative bacteria have relatively thin cell walls as in 
Fig. (1b) and do not retain purple color when stained with crystal violet.(2) These bacteria 
have an ability to cause various diseases termed generally as bacterial infections. 
Bacterial infections alone kill around 2 million people in the world.(3) They cause more 
than 2000 hospitalizations and 60 deaths each year in the United States.(4) To treat these 
bacterial infections, antibiotics are used. An antibiotic is a compound which either kills 
a 
b 
Fig. (1). (a) Cell wall with thick peptidoglycan 
in gram-positive bacteria. (b). Cell wall with 
negligible peptidoglycan layer in gram-negative 
bacteria 
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the bacteria (bactericidal) or inhibits their growth (bacteriostatic).(5) Antibiotics targeting 
specific species of bacteria are referred to as narrow-spectrum antibiotics where as 
antibiotics that show a wide range of activity on different species are known as broad 
spectrum antibiotics. Most of the bacteria developed resistance toward antibiotics due to 
their repeated use.(6) Bacterial infections have been rapid once such resistant strains were 
developed. Antibiotics, being the first line of defence, failed to kill bacteria reporting 
multiple deaths.(7) 
1.2.  Resistant bacteria 
The bacterial resistance is an evolutionary technique adapted by bacteria to 
survive extreme environments (like use of one or more antibiotics). Such resistant 
bacteria are called Multi Drug Resistant (MDR) bacteria. For example, a β- Lactamase 
producing strain of bacteria developed resistance towards β- Lactam antibiotics 
(Pencillin).(8) Some other examples of species which were resistant to antibiotics are 
Staphylococcus aureus for antibiotic named Methicillin and Enteroscoccus gallinarum 
for antibiotic, Vancomycin.(9) Macrolides, licosamides, and steptogramins are other 
examples of antibiotic classes for which both gram negative as well as gram positive 
bacteria gained resistance. This resistance was achieved through a process called target 
modification.(10) There is an increase in focus for the search of new drugs that overcome 
these resistant strains.(9) Many efforts have been made to inhibit such bacteria, but 
bacterial resistance is still a burning issue in chemotherapy of many bacterial 
infections.(11) Thus a huge focus was shifted toward nanotechnology, a leading field of 
science whose applications are widespread in fields like biological, biomedical, 
pharmaceutical, catalytical, and optoelectronics.(8) 
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1.3.  Nanotechnology 
New strategies have to be designed to treat resistant bacteria. Nanotechnology is 
one approach that gained significance as a novel platform in treating bacterial resistance. 
Nanotechnology is a field which deals with nanosized particles within a size range of 1 to 
100 nm, and they are called nanoparticles.(12) 
1.4.  Nanoparticles 
Nanoparticles exist in different shapes and different sizes. Nanoparticles were 
used to improve the efficiency of antibacterial agents or fight against MDR bacteria. 
These nanoparticles are involved in antibacterial property by acting as drug carriers as 
they can pass the biological membranes. They can be delivered in a controlled way such 
that targeted drug delivery is achieved and help in concentrating the drug at a concerned 
area.(13) 
1.5.  Types of nanoparticles 
Nanoparticles are classified based on their core material as inorganic and 
organic.(14, 15) The nanoparticles with organic core are found to be toxic for human use 
and they are also less stable at high temperature and pressure which causes problems 
during formulation. Inorganic materials like metals and metal oxides have gained 
importance in various fields and are more advantageous than organic materials in having 
a long shelf life, stability and are also nontoxic to the human biological systems.(16, 17) 
Inorganic core of nanoparticles are generally made of metals or metal oxides.(18) Metals 
like silver, and gold are widely used as conventional inorganic core materials. Similarly, 
metal oxides like zincoxide and titanium dioxide are used. Different types of 
nanoparticles emerged, but were found to be toxic to the biological cell. Among them are 
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silver, gold, zincoxide, and titanium dioxide, all of which gained importance in the field 
of nanotechnology as they are less toxic and also posess diversified applications.(19) 
1.6.  Zinc oxide nanoparticles (ZNPs) 
Zinc oxide is an inorganic metal oxide which has a wide variety of applications in 
many fields, especially in the field of pharmaceutics. ZNPs are widely used as an additive 
in ceramics, glass, cement, rubber, lubricants, paints, ointments, adhesives, pigments, 
foods, batteries, first aid tapes, etc.(20) Advantages of Zinc Nanoparticles (ZNPs) over 
other nanoparticles are its high catalytic efficiency, chemical stability and strong 
adsorption ability.(21) 
The mechanism of action of ZNPs is still open. Some authors suggest that ZNPs 
do not exhibit any antibacterial activity by themselves, but enhances the antibacterial 
activity of certain antibiotics, (21) Other suggest that ZNPs as nanofluids, show a 
significant antibacterial activity against E. coli.(16)  
Disadvantage:  
` ZNPs are found to induce toxicity in the cells which leads to the production of 
reactive oxygen species, oxidant injury, inflammation and finally the death of the cell.(22) 
The zebra fish embryonic toxicity test was conducted using ZNPs, which killed the 
embryos and thus was found to be toxic.(23) 
1.7.  Titanium oxide nanoparticles (TNPs)  
TNPs are not much used, but have a limited antibacterial activity. In their 
preparation, TNPs have to be co-doped with another metal and a non-metal in which 
silver and nitrogen are used respectively.(24) TNPs also carry the same toxic effects of 
ZNPs besides antibacterial activity.(22) 
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1.8.  Silver Nanoparticles (SNPs) 
The antibacterial properties of silver are known from ancient times. Silver and its 
ions are toxic to as many as 12 species of microorganisms.(25) Bacteria could not develop 
resistance towards silver ions, which paved a path to focus on SNPs and their 
antibacterial activity. SNPs are used in various applications like in dental work, on burn 
wounds, etc.(26) SNPs are also used as sensors and biomarkers, but the main applications 
of SNPs include its antibacterial use.(25)  
The exact mechanism of action of SNPs is still unknown. The proposed 
mechanism was that the SNPs would interact with the bacterial DNA and proteins there 
by inhibiting their growth. The other possible mechanism of action was that SNPs might 
disturb the respiratory chain in bacteria.(27) The SNPs might also be involved in physical 
processes like disruption of the cell membrane, and could also penetrate into the cell and 
leak the contents of bacteria. This effect is mainly observed in case of gram negative 
bacteria.(25) 
 In the preparation of nanoparticles there must be a reducing agent to reduce the 
crude form and then a capping agent to cap them and prevent them from aggregating. 
Some of the reducing agents used to synthesise SNPs are gallic acid (28), ascorbic acid (29) 
and citrates. The advantage of the citrate method over the other methods is that citrate 
capped the nanoparticles besides reducing, thus acting as both a capping agent and a 
reducing agent.(25) 
Disadvantages:  
Silver toxicity was discovered in 1983 by two scientists named Rungby and 
Danscher by injecting SNPs in rats. The SNPs damaged the neural cells of the brain. 
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They showed decrease in mitochondrial function in the liver cells, epidermal 
keratinocytes and fibroblasts.(30) Extensive use of these SNPs became a bio-hazard in the 
environment due to its toxicity. One example of such case was, SNPs toxicity towards 
Chlamydomonas reinhardtii, an aquatic single celled organism.(27) SNPs are also known 
for their toxicity and oxidative stress towards the human hepatoma cells.(31) SNPs were 
also tested on zebra fish embryos which suggested that the SNPs inhibit the natural 
development and also induce dose dependent toxicity.(32) SNPs are also believed to 
damage the DNA and cause chromosomal aberrations in humans, leading to cell cycle 
arrest.(33) 
1.9.  Gold nanoparticels (GNPs)  
Thus an alternate for the antibacterial activity showing nanoparticles were 
required. Gold being abundant and naturally available showed some antibacterial activity 
with much less toxicity. Among all nanoparticles, GNPs were found to be more stable 
and effective.(34) The use of gold nanoparticles dates back to the 16th century.(35) Apart 
from their antibacterial activity, GNPs were used in treatment of various diseases like 
epilepsy, dysentery, tumors, in dental fillings and in the treatment of syphilis. (34) GNPs 
were tested for their toxicity on human leukemia cells through exposure (a size range of 
4-18 nm) for three days and the GNPs were found to be non-toxic to the leukemia 
cells.(36) GNPs were also used for both medical and staining purposes. Gold nanoparticles 
also have applications in analytical methods such as colorimetric techniques, which is 
used to quantify heavy metal ions in aqueous solutions.(35) 
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1.10.  Applications of GNPs 
GNPs are used in various fields of biomedicine like biodistribution, photothermal 
and photodynamic therapy, drug and gene delivery, immunology, bio-imaging, analytical 
methods, and in various diagnostics.(37) GNP conjugates are also widely used as biolabels 
in bioimaging for various biophotonic technologies, including dark-field resonance 
scattering microscopy, confocal laser microscopy, diverse versions of two-photon 
scattering, optical coherence and acoustic tomography.(37) In medical applications, gold 
nanoparticles are used in treating B-chronic lymphocytic leukemia. The plasmon 
resonances of GNPs were used in DNA detection. Conjugating with enzymes, GNPs help 
in preparation of enzyme electrodes. Gold nanoparticles possess catalytic activity, hence 
they are used for reactions such as the water-gas shift reaction and selective oxidation of 
carbon oxide.(35) 
 GNPs are used in various advanced fields such as: 
• Biosensorics 
• Genomics 
• Clinical chemistry 
• Immunoassays 
• Immunresponse enhancement 
• Detection and control of microorganisms 
• Optical imaging of biological cells (including cancer cell imaging with resonance 
scattering, optical coherence tomography, photoluminescence and photoacoustic 
technique). 
• Cancer cell photothermolysis and 
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• Targeted drug delivery of drugs or genetic material and immunological 
substances. 
Along with the above applications, a huge focus was placed on delivery of the 
drug using a nanoparticle based vector which helped in reducing toxicity to cell and 
decresed the toxicity of the free drug.(38) 
1.11. Synthesis of GNPs 
Different ways of synthesis were investigated. The main theme in synthesis of 
GNPs in all of these process was to reduce colloidal solution using a reducing agent and 
by capping it using a capping agent. 
a. Preparation of GNPs with High temperature reduction: The preparation of 
GNPs was achieved using high temperatures and also solvents, to reduce colloidal 
gold. It can be performed in a single step, that is, the GNPs were formed with out 
the help of capping agent, avoiding the capping step after the reduction.  The 
resulting GNPs were mono dispersive and were found to be stable during the 
synthesis. Accelerated stability studies were performed, and it was observed that a 
small amount of aggregation was seen at a temperature of 105 oC which would 
also jeopardise the stability. Thus this process of producing GNPs using high 
temperatures was not effective although the GNPs attained were 
monodispersed.(39) 
b. Preparation of GNPs using Ultra violet irradiation: In this method, GNPs were 
synthesized using a low pressure mercury lamp and poly vinyl alcohol. The gold 
colloidal solution was mixed with the poly vinyl alcohol and then exposed to the 
lamp for 48 hours resulting in the production of GNPs with different shapes. No 
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consistencey among the shapes were observed and it was also a time consuming 
process.(40) 
c. Preparation of GNPs using aspartate reduction of gold chloride: The 
nanoparticles were prepared in an aqueous solution with the amino acid, aspartate, 
which acts as a reducing agent of tetraaurochlorate.(41)   
d. Preparation of GNPs using an amine: The preparations of GNPs were carried 
out using a multifunctional amine, which acted both as a reducing as well as a 
capping agent.(42) 
Other methods include, the synthesis using citrate reduction of gold 
colloidal solution, which is considered to be the standard in preparation of 
GNPs.(36) 
e. Biological methods: Not many, but few methods were developed where GNPs 
were synthesized using biological organisms. One of them is synthesis using 
Bacilius species. 
f. Green synthesis: Even though the GNPs are biocompatible, chemical methods 
used in their preparation can cause environmental hazards. To rule this out, a 
process called green synthesis has evolved, where the preparation does not 
include any hazardous chemicals. One such example of green synthesis of GNPs 
is preparation using Cinnamomum Zeylanicum leaf broth.(43)  
Disadvantage: All the green synthesis procedures are multiple step processes 
which require a reducing agent as well as a capping agent, and they consume 
more time and were less efficient. 
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g. Preparation of GNPs using Citrate reduction: Among the conventional 
methods of synthesis of GNPs, the most popular one has been the use of citrates 
for reduction of colloidal gold in water. The citrate method rules out every 
disadvantage that other methods have, but the GNPs prepared using the citrate 
method were found to be carcinogenic. 
In the current research, the method used was a novel, which has advantages such 
as the synthesis of GNPs being done in a single step, single phase, and moreover it is a 
green synthesis. No additional coating agents or reducing agents were used in this 
process. In the green synthesis, the antibiotic used was kanamycin, which acts as both 
capping and reducing agent. The GNPs were expected to improve the antibacterial 
activity of kanamycin thereby ruling out resistance. 
1.12. Kanamycin 
Kanamycin is a broad spectrum antibiotic, which is water soluble, insoluble in 
alcohol, and weakly basic.(44) It shows antibacterial activity against both gram positive 
and gram negative bacteria.(45) Studies reveal that, certain concentrations of kanamycin 
are more bactericidal than bacteriostatic.(46)  
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Kanamycin belongs to the class of amino glycosides. It has a broad range of 
antibacterial activity, that is, they act on both gram positive as well as gram negative 
bacterial strains. Kanamycin was a potent antimicrobial agent until the bacterial strains 
developed resistance towards it. The research was focused to overcome this resistance 
using the nanoparticles, as they possess antibacterial activity and act as good inert carriers 
of the drug. Nanoparticles were chosen because the bacteria could not develop resistance 
towards them. The synthesis involved in this effort was a completely green procedure and 
was performed in a single step. Kanamycin contains reducing functional groups for 
which it was expected to reduce the gold colloidal solution to synthesize GNPs. 
Kanamycin also acts as a capping agent to prevent aggregation of the GNPs. The whole 
synthesis was carried out in an aqueous medium. Coating of kanamycin on the GNPs was 
expected to show higher antibacterial activity than the regular antibiotic and was also 
tested against both strains to evaluate the antibacterial activity. 
Fig. (2). Chemical structure of kanamycin showing its functional groups 
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2. MATERIALS AND METHODS 
2.1. Materials 
Potassium Aurochlorate (KAuCl4), Kanamycin Sulfate, Lysogeny Broth (LB) 
agar, and Tryptic Soy (TS) agar were purchased from Aldrich, St. Louis, MO. The two 
bacterial strains were obtained from the biological specimen collection at Western 
Kentucky University. 
2.2.  Synthesis of GNPs 
 
 
 
 
 
 
 
 
The main theme of the synthesis was to reduce Au3+ to Au0. GNPs were prepared 
by reducing the KAuCl4 using kanamycin (single step) in an aqueous medium (single 
phase). This process of synthesis did not require any coating agent, as kanamycin acts as 
both reducing as well as capping agent. The gold colloidal solution of 300 ppm 
concentration was mixed with aqueous kanamycin solution of 1mg/ml concentration in 
an aqueous medium and incubated for 12 hours at 150 rpm and at a temperature of 37 ºC 
(47). The formation of GNPs was confirmed by the color change from colorless to light 
pink. The obtained GNPs were centrifuged at 15,000 rpm for 15 minutes, which make the 
Fig. (3). Synthetic scheme of kanamycin coated GNP 
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NPs settle at the bottom. These settled nanoparticles were resuspended in nano pure water 
and centrifuged again. This washing process was repeated several times so that the free 
kanamycin or colloidal gold solution is no longer present.  They were further processed 
using nanopure water and used for analysis.(47) 
2.3.  Characterization of Kan-GNPs 
The Kan-GNPs formed were characterized using various anaytical instruments. A 
Transmission Electron Microscope (TEM) was used to determine the shape and size of 
the nanoparticles. 400 mesh size copper grids were used in the imaging. The grids were 
washed with hydrochloric acid, water and acetone and allowed to sit for drying. These 
washed grids were coated with firmvar. Approximately 5 µL of Kan-GNP solution was 
added to the grid and then viewed under the microscope.(47) 
To determine the interactions between the capping agent and nanoparticle’s 
surface, a Perkin Elmer Spectrum 100-Fourier Transform Infrared Spectroscopy (FTIR) 
was used. The blank used was kanamycin powder. The Kan-GNP solution was 
concentrated by removing the extra suprenatent liquid and dried in the ependorf using a 
heating pan. The characterized nanoparticles were further analysed for their antibacterial 
activity.  
2.4.  Antibacterial activity 
The efficiency of the synthesized nanoparticles was determined using 
antibacterial experiments. In all the antibacterial experiments performed, a bacterial 
culture prepared from 100 µL glycerol stock in 10 ml of fresh autoclaved medium was 
used. The antibacterial activity was tested against two strains representing two different 
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classes, Escherichia coli (gram negative) and Staphylococcus epidermidis (gram 
positive). 
a. Turbidimetry  
 
Turbidimetry is a method, in which the effect of antibiotics or other drugs is 
measured in a liquid media by using a photoelectric colorimeter. It is a process of 
measuring loss of intensity of transmitted light due to scattering effect of particles 
suspended in the sample. Turbidimetry is one of the two optical methods, the other one 
being Microdilution (Plate count), used to determine the minimum inhibitory 
concentration (MIC).(48) MIC is the concentration of an antibacterial agent required to 
inhibit growth of bacterial cultures. In the field of biology, turbidimetry is also used to 
find the number of cells in a solution. The data from turbidity measurements were used to 
construct growth curves. In this process different concentrations of Kan-GNPs were 
treated with constant amount of bacteria in sterile liquid medium and incubated for 12 
hours at 37 ºC. With a time interval of an hour, the bacteria were quantified by measuring 
their optical density (OD) at 600 nm using a Spectronic-20 instrument. The OD of 
bacterial cultures in the absence of Kan-GNPs was also determined, which acts as a 
control. 
b. Spread plate technique 
 
Spread plate technique is a biological experiment, where the viable bacteria are 
measured in accordance with the concentration of antimicrobial agent applied.(49) In this 
method, the sterile nutrient agar medium was prepared and allowed to solidify on a petri 
dish, later the bacterial suspension was spread over the solidified agar medium with the 
aid of a sterile spreader. (8) The petri dish was allowed to incubate at the appropriate 
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temperature for a certain time and then observed for the bacterial colonies. The two 
bacterial strains (E. coli, S. epidermidis) were treated with different concentrations of 
Kan-GNPs and spread on a solid agar growth medium and incubated at 37 ºC for 12 
hours. The bacteria start to form colonies which are visible. This helps in the 
determination of viable bacteria with different doses of Kan-GNPs. The number of 
colony forming units was counted using a flow cytometer. 
c. Agar well diffusion method 
 
Agar diffusion techniques have been widely used in microbiological assays. In 
this method, the antibiotic present in the agar wells, diffuses into the pre-inoculated 
solidified agar medium, thereby inhibiting the growth of the microorganisms.(49) By using 
a cork borer, wells of size ranging from 6 mm - 8 mm were aseptically punched by 
maintaining at least 30 mm distance between adjacent wells. The fixed amount of test 
solution (antibiotic, plant extract) was poured into the wells and incubated for 24 hours at 
37 ºC. In this experiment, the wells were filled with traditional antibiotic (kanamycin 
stock solution) which is used as control, as well as the Kan-GNPs. The zone of inhibition 
was determined. This provides the potency of the nanoparticles in comparison with the 
antibiotic. 
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3. RESULTS 
3.1.  Synthesis of Kan-GNP 
Gold colloidal solution is easily reduced from Au3+ to Au0 to form gold 
nanoparticles, but has to be capped to avoid aggregation. Thus a reducing agent as well as 
a capping agent were required. In major synthetic procedures, use of different reducing 
agents and capping agents were shown but none of them were found effective due to their 
respective disadvantages.(39 - 43) Kanamycin contains reducing functional groups along 
with 7-hydroxyl groups and was used in the research expecting to reduce the colloidal 
gold solution in an aqueous medium. To determine the exact concentration of gold 
solution and kanamycin to form the desired Kan-GNP, different trials were performed by 
keeping the concentration of kanamycin constant at 1 mg/ml and by varying the 
concentration of the gold solution as shown in table 1. The reduction process was carried 
out in test tubes and incubated these test tubes for 12 hours in an incubator at 37 ºC. The 
change of color from colorless to dark pink/purple was indicative of successful reduction 
of gold colloidal solution.(54) As the concentration of gold increased from 100 ppm to 600 
ppm, the intensity of the color increased as shown in Fig. (4). The increase in the 
intensity of color was expected to be a representation of excessive reduction. Among all 
the concentrations tried, the 300 ppm of gold solution showed promising color with 1 
mg/ml kanamycin concentration. Similar trials were performed with constant 
concentration of gold solution at 300 ppm and varying the kanamycin concentration as in 
table 2. In these trails, as the concentration of kanamycin stock was changed, the color 
decreased in intensity as shown in Fig. (5), and this is due to the insufficient gold 
colloidal solution to reduce by the kanamycin. 1 mg/ml concentration of kanamycin 
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showed a promising color. These derivations from the synthesis were confirmed by 
further characterization of Kan-GNPs. 
3.2.  Characterization of Kan-GNPs  
Kan-GNPs formed at 300 ppm and 1 mg/ml were chosen. The sample was washed 
several times to eliminate the excess kanamycin or unreduced gold colloidal solution. 
This was achieved by taking the sample in small volumes and diluting it with nanopure 
water and centrifuged at a speed of 15000 rpm until the Kan-GNPs settled at the bottom. 
The supernatant solution was removed using a pipette without disturbing the pellet. This 
pellet was again resuspended in nanopure water. The washing process was repeated 
several times. Washing the sample several times was considered important as the 
impurities might interfere with the results.    
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Fig.  (4). Test tube pictures of Kan-GNP to show the color change indicating the 
reduction reaction. These are prepared with different concentrations of gold and 
concentration of 1mg/ml of kanamycin. 
 
Table 1. Gold dependent Kan-GNP synthesis showing formation of nanoparticles using 
different concentrations of gold ranging from 100 ppm to 600 ppm prepared from gold 
colloidal stock solution, which suggests that the 300 ppm gold concentration yielded 
good number and desirable form of nanoparticles.  
 
 
 
 
 
 
 
 
 
 
Concentration of gold Colour observed Formation of nanoparticles 
100 ppm Light pink Low in number 
200 ppm Light pink Resaonable 
300 ppm Pink Very good 
400 ppm Pink Clusters 
500 ppm Dark pink Clusters 
600 ppm Dark pink Clusters 
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Fig. (5). Test tube pictures of Kan-GNPs to show the color change indicating the 
reduction reaction. These are prepared with different concentrations of kanamycin and 
concentration of 300 ppm of gold 
 
 
Concentration of Kanamycin Colour observed Formation of nanoparticles 
0.25 mg/ml Pink Cluster 
0.5 mg/ml Pink Good 
1 mg/ml Pink Very good 
2 mg/ml Pink Good 
3 mg/ml Light Pink Low in number 
4 mg/ml No colour change No formation of GNPs 
Table 2. Kanamycin dependent Kan-GNP synthesis showing formation of 
nanoparticles using different concentrations of kanamycin ranging from 0.25 
mg/ml to 4 mg/ml prepared from the kanamycin stock solution, which suggest 
that the 1mg/ml kanamycin concentration yielded a good number and 
desirable form of nanoparticles 
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3.3.  Transmission Electron Microscopy (TEM) 
TEM is an analytical instrument in which the sample is treated with a high 
intensity electron beam in a vaccum. The scattering of this high intensity beam gives a 
dark image on the microfilm, which can be photographed. The resolution of a TEM is 
higher than a conventional microscope, which is in the nano range. TEM helps in 
providing the shape and size of the nanoparticles. To view a sample in TEM, a copper 
grid is used, which is thoroughly cleaned and coated with firmvar. Different samples of 
Kan-GNPs mentioned in the trials were viewed under TEM which revealed the 
morphological character of nanoparticles. The TEM results in Fig. (6) suggest that the 
nanoparticles are monodispersed and have a unique size at a concentration of 300 ppm 
gold stock solution and the TEM results in Fig. (7) indicate that the 1mg/ml concentration 
of kanamycin gave desirable results. The other images show either a low number of 
nanoparticles or of clusters. These pictures confirm the hypothesis made during the 
synthesis. The TEM results also suggest that the shape of the nanoparticles was ranging 
approximately 15 ± 3 nm. 
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Fig. (6). To confirm the reduction and to determine the size of the nanoparticles, TEM 
imaging is done. From the above data 300 ppm of gold concentration showed consistent 
shape and a good number of nanoparticles and the size range was found to be 15 ± 3 nm.  
Fig. (7). To confirm the formation of nanoparticles and to determine the size of the 
nanoparticles, TEM imaging is performed. From the above data 1mg/ml 
concentration of kanamycin showed consistent shape and a good number of 
nanoparticles and the size range was found to be 15 ± 3 nm. 
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3.4.  UV/Vis spectroscopy  
The UV/Vis spectroscopy is a widely used analytical technique to determine the 
intensity of light either transmitted or absorbed. The absorbance of the light or the 
scattering of the light depends on the physical properties of the sample. Nanoparticles 
exhibit peaks at specific wavelengths due to their surface plasmon resonance.(55) This 
scattering of the light in SPR band depends on the size of the nanoparticle and also their 
dispersion in the medium. The UV/Vis spectroscopy of Kan-GNP yielded a peak at 
approximately 550 nm as shown in Fig. (8a), which indicates that the peak was within the 
range of the SPR band. This helps in confirmation that the Kan-GNPs were in the size 
range of about 15 ± 3 nm and also exist in spherical shape. 
3.5.  SEM-EDS analysis   
SEM is an analytical instrument which helps in providing 3-D images. SEM can 
be fused to a high energy X- Ray emitting device termed EDS. These X-rays help in 
determination of presence, amount, and distribution of elements in the sample.The 
principle involved in EDS is when the sample is bombarded with high energy X-ray 
beam, they excite and provide a peak. These peaks are confined to particular elements, 
which provide the elementary composition of the sample. The copper grid with Kan-GNP 
was placed on an aluminum stab and viewed under SEM/EDS spectroscopy. As expected, 
the reduced gold concentration was found to be 86.34 w% and other elements include 
6.52 w% of oxygen and 7.14 w% of carbon as shown in Fig. (8c).  
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Fig. (8). (a) UV/Visible spectrum of Kan-GNP with a broad peak at approximately 550 
nm. This indicates that it is a heterogenous compound and also suggests that the 
nanoparticles formed were coated effectively.(b) TEM image of Kan-GNP which was 
synthesized using 1mg/ml kanamycin stock solution and 300 ppm gold concentration. 
The size of the nanoparticles was approximately found to be 15 ± 3 nm. (c) The SEM 
image along with the dispersion spectrum of the Kan-GNPs. This showed 86.34 w% of 
gold, 6.52 w% of oxygen and 7.14 w% of carbon.  
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3.6.  FTIR spectroscopy 
Every functional group exists in its own vibrational mode. These vibrations are 
sensitive toward any change in the functional group. This provides the information of 
interaction between two elements. FTIR was performed on the Kan-GNPs to determine 
the interactions between kanamycin and GNPs. The spectrum showed a shift between 
2833.54 cm-1 to 3115.51 cm-1 as shown in Fig. (9), which is a typical stretch for a 
hydroxyl functional group, indicating the involvement of hydroxy groups in bonding of 
kanamycin with the nanoparticles. Other minor stretchings were also found between 
2117.0 cm-1 to 2120.79 cm-1 and 1591.0 cm-1 to 1608.95 cm-1 indicating the involvement 
of  triple bond carbon and carboxyl group respectively. 
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Fig. (9). FTIR spectrum of a) Kan-GNP and b) control kanamycin stock reveals a stretch 
at 2833.54 cm-1 to 3115.51 cm-1, a typical stretch for a hydroxyl group indicating the 
involvement of hydroxy groups in bonding with the nanoparticles. Other minor 
stretchings were also found at 2117.0 cm-1 to 2120.79 cm-1 and 1591.0 cm-1 to 1608.95 
cm-1 indicating the involvement of  triple bond carbon and carboxyl group respectively. 
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3.7. Antibacterial activity of Kan-GNPs tested against E. coli  
3.7.1. Turbidimetry  
Turbidimetry is a biological process of quantifying the bacterial growth. It is a 
measurement of scattering of light due to the bacteria present in a suspension. More the 
bacteria, more light will be scattered, indicating increased growth and vice versa. The 
light scattering was observed at 600 nm. Turbidimetry also provides the information of 
MIC. The turbidity of the E. coli was measured in a liquid medium. The bacterial culture 
treated with different concentrations of Kan-GNPs and a culture with no Kan-GNP 
(control), were incubated for 12 hours. The optical density was measured at 600 nm for 
every hour and the results were plotted in a graph. They suggest that, as the concentration 
of the Kan-GNPs increased, the growth of the cells declined as shown in Fig. (10). The 
MIC was found to be approximately 0.15 mg/ml where no growth of the bacteria was 
observed. 
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Fig. (10). The growth curve of E. coli treated with different concentrations of 
Kan-GNP. The concentrations used were 0 mg/ml (control), 0.02 mg/ml, 0.04 
mg/ml, 0.06 mg/ml, 0.08 mg/ml, 0.1 mg/ml, and 0.15 mg/ml. Among them the 
minimum inhibitory concentration (MIC) was found to be 0.15mg/ml. 
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3.7.2. Spread plate assay  
Spread plate technique is the measurement of surviving bacteria after treating the 
bacterial culture with specific antibiotics. The bacterial cultures in liquid medium with 
varying concentrations of Kan-GNPs were spread on a solid agar well with an autoclaved 
spreader. A control was also made in which bacterial culture without the treatment of 
Kan-GNP was spread on the agar plate. The results after the incubation of 12 hours 
suggest that the Kan-GNP was more effective and showed a dose dependent action on E. 
coli as shown in the Fig. (11a). The graphs relative to the spread plate assay was plotted 
with number of colonies on the Y- axis and concentration of Kan-GNPs on the X- axis as 
shown in Fig. (11b). This suggests that the MIC found in the turbidity measurements 
were in total agreement with that of the spread plate assay.  
 
 
 
 
 
 
 
 
 
 
  
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (11). (a) Spread plate assay performed on E. coli strain by treating the strain with 
different concentrations of Kan-GNPs. The control is non treated bacterial strain 
exhibiting a large number of colonies which decreased as the concentration of Kan-
GNP was increased. (b) A histogram of the spread plate assay which shows a dramatic 
decline in the growth of the bacteria from approximately 300 colonies in the control to 0 
in 0.12 mg/ml. 
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3.7.3. Agar well diffusion assay  
The agar well diffusion method determines the potency of the Kan-GNPs in 
comparison to the control (kanamycin stock). Similar to the disk diffusion assay, agar 
well diffusion assay was performed, in which the bacterial preculture grown in agar 
medium was treated with different concentrations of Kan-GNPs in the bores. This 
provides a zone of inhibition of growth that is, the extent of antibacterial agent diffusing 
across a solid agar to kill bacteria. The larger the zone of inhibition the more potent it 
would be. The petri plates were incubated for 12 hours and the radius of the zone of 
inhibition was measured. For E. coli with Kan-GNP, the zone of inhibition was found 
maximum of approximately 0.6 cm at 0.24 mg/ml as shown in Fig. (12a). The graphs 
relative to the agar well diffusion assay was plotted with the radius of the zones on theY- 
axis and concentration of Kan-GNPs on the X- axis as in Fig. (12b). A similar 
experiment was performed with kanamycin alone as a control as in Fig. (13a), in which 
the zone of inhibition was maximum at 1.5 mg/ml. The comparative result suggests that 
the Kan-GNPs were more effective at a lower concentration than the kanamycin control 
to attain similar antibacterial activity.  
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Fig. (12). (a) Agar well diffusion assay performed on E. coli strain by treating the 
strain with different concentrations of Kan-GNPs in a bore across the solid agar. The 
radius of the zone around the well was measured and found maximum at 0.24 
mg/ml. (b) A histogram of the agar well diffusion assay with Kan-GNP which 
shows a dramatic increase in the radius of the zone with a maximum radius of 
approximately 0.6 cm at 0.24 mg/ml.  
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Fig. (13). (a) Agar well diffusion assay performed on E. coli strain by treating the 
strain with different concentrations of kanamycin in a bore across the solid agar. 
The radius of the zone around the well was measured and found maximum at 1.5 
mg/ml. (b) A histogram of the agar well diffusion assay with kanamycin which 
shows an increase in the radius of the zone with a maximum radius of 
approximately 0.8 cm at 1.5 mg/ml.  
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3.8.  Antibacterial activity of Kan-GNPs tested against S. epidermidis  
3.8.1. Turbidimetry  
The turbidimetric measurements of S. epidermidis showed similar results as that 
od E. coli. When the concentration of the Kan-GNP was increased, the growth of the 
bacteria declined, which is represented in the growth curve in Fig. (14). The MIC was 
found to be 0.08 mg/ml. 
3.8.2. Spread plate assay  
The spread plate assay of S. epidermidis reveals that, the control has around 300 
colonies of bacteria, and 0.06 mg/ml treated agar well showed no colonies, which is 
shown in Fig. (15a). The results were depicted in a histogram with number of colonies on 
the Y- axis and concentration of Kan-GNP on the X- axis Fig. (15b). 
3.8.3. Agar well diffusion assay  
In the agar well diffusion assay of S. epidermidis with Kan-GNP, the zone of 
inhibition was maximum at approximately 0.6 cm at 0.24 mg/ml as shown in Fig. (16a). 
The graphs relative to the  diffusion assay was plotted with the radius of the zones on the 
Y- axis and concentration of Kan-GNPs on the X- axis, shown in Fig. (16b). A similar 
experiment was performed with kanamycin alone as a control, shown in Fig. (17a & 
17b), in which the zone of inhibition was maximum at 1.5 mg/ml. The above result 
suggests that, the Kan-GNPs were more effective than the kanamycin (control). 
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Fig. (14). The growth curve of S. epidermidis treated with different concentrations 
of Kan-GNP. The concentrations used are 0 mg/ml (control), 0.02 mg/ml, 0.03 
mg/ml, 0.04 mg/ml, 0.05 mg/ml, 0.6 mg/ml, and 0.08 mg/ml. Among them the 
minimum inhibitory concentration (MIC) was found to be 0.08 mg/ml. 
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Fig. (15). (a) Spread plate assay performed on S. epidermidis strain by 
treating the strain with different concentrations of Kan-GNPs. The control is 
non treated bacterial strain exhibiting a large number of colonies which 
decreased as the concentration of Kan- GNP was increased. (b) A histogram 
of the spread plate assay which shows a dramatic decline in the growth of the 
bacteria from approximately 280 colonies in the control to 0 in 0.06 mg/ml.  
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Fig. (16). (a) Agar well diffusion assay performed on S. epidermidis strain by 
treating the strain with different concentrations of Kan-GNPs in a bore across 
the solid agar. The radius of the zone around the well was measured and found 
maximum at 0.24 mg/ml.(b) A histogram of the agar well diffusion assay with 
Kan-GNP which shows a dramatic increase in the radius of the zone with a 
maximum radius of approximately 0.6 cm at 0.24 mg/ml.  
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Fig. (17). (a) Agar well diffusion assay performed on S. epidermidis strain 
by treating the strain with different concentrations of kanamycin in a bore 
across the solid agar. The radius of the zone around the well was measured 
and found maximum at 1.5 mg/ml. (b) A histogram of the agar well 
diffusion assay with kanamycin which shows an increase in the radius of 
the zone with a maximum radius of approximately 0.8 cm at 1.5 mg/ml. 
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4. DISCUSSION 
 
Increase in focus towards the nanoparticles was due to the development of multi 
drug resistant strains. Kanamycin was found to be more potent and effective until bacteria 
developed resistance against it.(7) Among different types of nanoparticles, GNPs were 
found to be effective and non toxic. It was a challenge to synthesize environmental 
friendly GNPs, which was overcome by the green synthesis. The focus of the research 
was to counter the resistance with new techniques in a bio-friendly manner.  The main 
theme of the synthesis was to reduce colloidal gold using kanamycin in a single phase, 
single step and in bio-friendly process. Kanamycin helps in both reduction as well as 
capping of the nanoparticles. The formation of Kan-GNPs was noticed by the color 
change from colorless to pink/purple. 
The nanoparticles were characterized using various techniques. A TEM was used 
to determine the morphological characters, i.e., the TEM images provide the size and 
shape of the nanoparticles.  The nanoparticles synthesized were found to be in the range 
of 15 ± 3 nm and were also found to be resuspendable without any clusters. The UV/Vis 
spectroscopy was performed to determine the optical properties of the nanoparticles. The 
Kan-GNP yielded a spectrum with a peak around 550 nm wavelength which was a 
characteristic peak for GNPs in SPR band. The FTIR was performed to find the 
interactions between the nanoparticles and a coating agent, which revealed that, the bond 
between them is due to the interaction of hydroxyl group of Kanamycin with GNP. This 
interaction was confirmed by observing a stretch in the hydroxyl region in FTIR 
spectrum which was compared to that of the control’s spectrum. The SEM-EDS data 
reveals more insight towards the elemental compostion of the Kan-GNPs. The peaks 
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were relative to gold even after several washings, indicating the generated GNP is the 
result of reduced colloidal solution of gold. The elemental percentage was found to be 
86.34 w% of gold, 6.52 w% of oxygen and 7.14 w% of carbon. 
The antibacterial effects were tested against two strains: gram positive and gram 
negative bacteria. Turbidity measurements were performed by incubating liquid agar 
cultures of the strains and by measuring the optical density at 600 nm. Thus MIC values 
were calculated for both the strains from turbidity measurements. For E. coli the MIC 
was found to be 0.15 mg/ml and for S. epidermidis the MIC was found to be 0.08 mg/ml. 
These values suggest that the Kan-GNPs exhibit bacteriostatic effect.   
Spread plate assays were performed to evaluate the bactericidal effect of Kan-
GNP and by comparing it with the kanamycin control. The assays showed a great 
difference in the number of colonies for Kan-GNP, when compared to that of kanamycin 
control for both the strains. The number of colonies decreased dramatically as the 
concentration of the Kan-GNP was increased for both the strains. This indicates that the 
Kan-GNPs were more potent than the control kanamycin.  
Agar well diffusion was also performed, in which the zone of inhibition was 
calculated after treating solid culture medium with different concentrations of Kan-GNPs 
and also by comparing them with kanamycin. The radius of the zone of inhibition for 
Kan-GNP treated E. coli was found to be 0.6 cm at 0.24 mg/ml, whereas the control 
showed the same radius at around 1.2 mg/ml. Similarly the radius of the zone of 
inhibition for Kan-GNP treated S. epidermidis was found to be 0.6 cm at 0.24 mg/ml, 
where as the control showed the same radius at around 1.2 mg/ml. The results of agar 
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well diffusion assay reveal that the Kan-GNP was found to be more effective than the 
traditional antibiotic.   
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5. CONCLUSION 
 
GNPs were successfully synthesized by a simple procedure, in a single step, 
single phase, bio-friendly manner, and were efficiently coated with kanamycin. The 
synthesized nanoparticles were well characterized using various techniques, which 
confirmed that the Kan-GNPs were stable. They exist in the size range of 15 ± 3 nm. The 
hydroxyl groups of kanamycin were found to interact with the GNPs, which not only 
reduces the NPs but caps them as well. 
 The antibacterial experiments were conducted on E. coli (gram negative bacteria) 
and S. epidermidis (gram positive bacteria). The MIC was determined for both the 
strains. The MIC for S. epidermidis was found to be 0.08 mg/ml and for E. coli was 0.15 
mg/ml. Thus Kan-GNPs were found to be more effective in treating gram positive 
bacteria than the gram negative bacteria. The difference in the effectiveness is accounted 
for the difference in the cell wall thickness. The results suggest that, unlike the traditional 
antibiotic, kanamycin, Kan-GNPs showed enhanced antibacterial activity on both the 
strains. 
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